Education
About Us
Working with TipRanks
Follow Us
Genscript Biotech (GNNSF)
OTHER OTC:GNNSF
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 594.49M | $ 839.53M | $ 625.70M | $ 490.10M | $ 390.85M |
| Gross Profit | $ 272.13M | $ 409.55M | $ 304.08M | $ 282.52M | $ 255.89M |
| Operating Income | $ 9.28M | $ -415.79M | $ -438.11M | $ -379.29M | $ -204.55M |
| EBITDA | $ 70.43M | $ -249.42M | $ -389.04M | $ -341.57M | $ -174.71M |
| Net Income | $ 2.96B | $ -95.48M | $ -226.85M | $ -358.71M | $ -204.94M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 621.18M | $ 1.93B | $ 1.46B | $ 1.41B | $ 772.38M |
| Total Assets | $ 5.28B | $ 3.39B | $ 2.55B | $ 2.23B | $ 1.45B |
| Total Debt | $ 723.74M | $ 416.99M | $ 349.80M | $ 156.45M | $ 55.00M |
| Net Debt | $ 591.75M | $ -1.03B | $ -674.20M | $ -1.02B | $ -574.05M |
| Total Liabilities | $ 954.91M | $ 1.34B | $ 1.18B | $ 846.17M | $ 631.82M |
| Stockholders' Equity | $ 4.32B | $ 1.39B | $ 1.01B | $ 1.05B | $ 901.71M |
| Cash Flow | |||||
| Free Cash Flow | $ -72.27M | $ -444.62M | $ -336.40M | $ -269.83M | $ -272.97M |
| Operating Cash Flow | $ 75.65M | $ -286.91M | $ -120.29M | $ -136.79M | $ -151.09M |
| Investing Cash Flow | $ -1.46B | $ -357.73M | $ -443.30M | $ -212.55M | $ -100.17M |
| Financing Cash Flow | $ 66.52M | $ 1.07B | $ 419.32M | $ 902.14M | $ 624.20M |